
CAMBRIDGE, Mass. — An explosion of biological data will lead to the first drug candidates discovered by an artificial intelligence system within the next few years, a feat that promises to change the way pharmaceutical companies conduct research.
That was a consensus opinion that emerged among experts in machine learning who spoke at the STAT Summit Thursday about the use of AI in the pharmaceutical industry.